Clincosm LogoSign in Get a demo

Diabetes Mellitus, Type 2

Showing NaN - NaN of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, PreDiabetes Trial in Berlin (Usage of the PROTEIN-Application)

Completed
  • Diabetes Mellitus, Type 2
  • PreDiabetes
  • Usage of the PROTEIN-Application
  • Berlin, Germany
    Charité Univesitätsmedizin Berlin
Jul 11, 2023

Diabetes, Type 2 Trial in United States (LY3457263, Placebo, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +4 more
Dec 8, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin DR
  • +3 more
  • Glendale, Arizona
  • +86 more
Jun 7, 2022

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Berlin (Co-formulation NNC0480 0389+Semaglutide A 10/1 mg/mL, semaglutide 1.34 mg/mL (), Semaglutide

Completed
  • Diabetes Mellitus, Type 2
  • Co-formulation NNC0480 0389+Semaglutide A 10/1 mg/mL
  • +3 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Mar 31, 2022

Diabetes, Type 2 Trial in Berlin (Oral semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Berlin, Germany
    Novo Nordisk Investigational Site
Mar 23, 2022

Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • 4 mm x 32G pen needle (Nano)
  • 8mm x 31G pen needle (Short)
  • Minneapolis, Minnesota
  • +2 more
Feb 28, 2022

Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)

Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 1.34 mg/mL
  • +4 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 3, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Ischemic Heart Disease Chronic, Diabetes, Type 2 Trial in Germany (lifestyle intervention, usual care)

Completed
  • Ischemic Heart Disease Chronic
  • Diabetes Mellitus, Type 2
  • lifestyle intervention
  • usual care
  • Aachen, Germany
  • +9 more
Nov 4, 2021

Diabetes, Type 2 Trial in Berlin (NNC0480-0389)

Recruiting
  • Diabetes Mellitus, Type 2
  • Berlin, Germany
    Novo Nordisk Investigational Site
Sep 3, 2021

Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Bahía Blanca, Argentina
  • +213 more
Jul 23, 2021

Looking at How Semaglutide Works in People With Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
  • Amberg, Germany
  • +94 more
Jul 23, 2021

Diabetes, Type 2 Trial in Berlin (Insulin icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Berlin, Germany
    Novo Nordisk Investigational Site
Mar 5, 2021

Diabetes, Type 2 Trial in United Kingdom, United States (BYM338 10 mg/kg, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BYM338 10 mg/kg
  • Placebo
  • Anaheim, California
  • +8 more
Dec 9, 2020

Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Buenos Aires, Santa Fe, Argentina
  • +186 more
Dec 17, 2020

Diabetes, Type 2 Trial in Worldwide (vildagliptin + metformin, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Pine Bluff, Arkansas
  • +62 more
Dec 11, 2020

Diabetes, Type 2, Renal Insufficiency Trial in Worldwide (vildagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • Buenos Aires, Argentina
  • +89 more
Dec 11, 2020

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Diabetes, Type 2, Non-Alcoholic Fatty Liver Disease Trial in Canada, United States (BFKB8488A, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Non-Alcoholic Fatty Liver Disease
  • Anniston, Alabama
  • +17 more
Mar 25, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Diabetes, Type 2 Trial in Berlin (Semaglutide, 0.25 mg, Semaglutide, 0.5 mg, Semaglutide, 1.0 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Semaglutide, 0.25 mg
  • +4 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 7, 2020